The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Labcorp Holdings Inc (NYSE: LH) closed at $261.48 down -1.61% from its previous closing price of $265.76. In other words, the price has decreased by -$1.61 from its previous closing price. On the day, 0.86 million shares were traded. LH stock price reached its highest trading level at $265.555 during the session, while it also had its lowest trading level at $259.73.
Ratios:
For a deeper understanding of Labcorp Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 36.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.70. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.67.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $276.
Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $250 to $300.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 11 ’25 when Schechter Adam H sold 5,745 shares for $262.75 per share. The transaction valued at 1,509,499 led to the insider holds 87,574 shares of the business.
Schechter Adam H bought 5,745 shares of LH for $1,509,499 on Nov 11 ’25. On Oct 31 ’25, another insider, Parham Richelle P, who serves as the Director of the company, sold 7,009 shares for $254.28 each. As a result, the insider received 1,782,273 and left with 2,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 21728989184 and an Enterprise Value of 27677992960. As of this moment, Labcorp’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.68, and their Forward P/E ratio for the next fiscal year is 14.92. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.57 while its Price-to-Book (P/B) ratio in mrq is 2.50. Its current Enterprise Value per Revenue stands at 2.011 whereas that against EBITDA is 14.096.
Stock Price History:
The Beta on a monthly basis for LH is 0.99, which has changed by 0.14270973 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, LH has reached a high of $293.72, while it has fallen to a 52-week low of $209.38. The 50-Day Moving Average of the stock is -3.17%, while the 200-Day Moving Average is calculated to be 1.68%.
Shares Statistics:
For the past three months, LH has traded an average of 755.04K shares per day and 731960 over the past ten days. A total of 83.00M shares are outstanding, with a floating share count of 82.65M. Insiders hold about 0.31% of the company’s shares, while institutions hold 97.16% stake in the company. Shares short for LH as of 1763078400 were 3211771 with a Short Ratio of 4.25, compared to 1760486400 on 2438588. Therefore, it implies a Short% of Shares Outstanding of 3211771 and a Short% of Float of 5.04.
Dividends & Splits
According to the company, the forward annual dividend rate for LH is 2.88, from 2.88 in the trailing year. Against a Trailing Annual Dividend Yield of 0.010836845. The current Payout Ratio is 32.58% for LH, which recently paid a dividend on 2025-11-26 with an ex-dividend date of 2025-11-26. Stock splits for the company last occurred on 2023-07-03 when the company split stock in a 1164:1000 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 15.0 analysts. The consensus estimate for the next quarter is $4.11, with high estimates of $4.3 and low estimates of $3.98.
Analysts are recommending an EPS of between $16.41 and $16.16 for the fiscal current year, implying an average EPS of $16.33. EPS for the following year is $17.55, with 18.0 analysts recommending between $18.08 and $16.86.
Revenue Estimates
A total of 13 analysts believe the company’s revenue will be $3.56B this quarter.It ranges from a high estimate of $3.61B to a low estimate of $3.52B. As of. The current estimate, Labcorp Holdings Inc’s year-ago sales were $3.33BFor the next quarter, 13 analysts are estimating revenue of $3.5B. There is a high estimate of $3.54B for the next quarter, whereas the lowest estimate is $3.46B.
A total of 17 analysts have provided revenue estimates for LH’s current fiscal year. The highest revenue estimate was $14.04B, while the lowest revenue estimate was $13.96B, resulting in an average revenue estimate of $14B. In the same quarter a year ago, actual revenue was $13.01BBased on 17 analysts’ estimates, the company’s revenue will be $14.62B in the next fiscal year. The high estimate is $14.88B and the low estimate is $14.47B.
